NCT00477373View on ClinicalTrials.gov

Gulf Evaluation of VAlproate (Depakine Chrono) in maNia Study

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

December 31, 2007

Conditions
Bipolar Disorder
Interventions
DRUG

depakine chrono

Depakine Chrono 500 mg

Trial Locations (4)

Unknown

Sanofi-aventis administrative office, Bahrain

Sanofi-aventis administrative office, Kuwait City

Sanofi-Aventis Administrative Office, Muscat

Sanofi-aventis administrative office, Qatar

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00477373 - Gulf Evaluation of VAlproate (Depakine Chrono) in maNia Study | Biotech Hunter | Biotech Hunter